Anzeige
Mehr »
Dienstag, 21.07.2026 - Börsentäglich über 12.000 News
42 Proben im Labor - Jetzt beginnt die spannendste Phase für diese Wolfram-Aktie
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von x3news

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
08.06.Eurohold Bulgaria AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
08.06.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
08.06.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
08.06.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
08.06.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
05.06.Bulgarian Real Estate Fund REIT: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
05.06.Eurohold Bulgaria AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
05.06.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
05.06.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
05.06.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
05.06.Tchaikapharma High Quality Medicines AD: Consolidated quarterly financial report
05.06.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
05.06.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
04.06.Eurohold Bulgaria AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
04.06.MFG Invest AD: Other unregulated information
04.06.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
04.06.Wiser Technology AD: Other unregulated information
04.06.Eurohold Bulgaria AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
04.06.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
03.06.Eurohold Bulgaria AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
03.06.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
03.06.Eurohold Bulgaria AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
03.06.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
03.06.CB Bulgarian American Credit Bank AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
02.06.Shelly Group SE: Other unregulated information